ArticleBreast cancer research and treatment2024

Uptake of screening and risk-reducing recommendations among women with hereditary breast and ovarian cancer syndrome due to pathogenic BRCA1/2 variants evaluated at a large urban comprehensive cancer center.

Hadeel Assad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.